Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Antibiotic Resistance in the Environment [[electronic resource] ] : A Worldwide Overview / / edited by Célia M. Manaia, Erica Donner, Ivone Vaz-Moreira, Peiying Hong
| Antibiotic Resistance in the Environment [[electronic resource] ] : A Worldwide Overview / / edited by Célia M. Manaia, Erica Donner, Ivone Vaz-Moreira, Peiying Hong |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (XII, 344 p. 1 illus.) |
| Disciplina | 616.9041 |
| Collana | The Handbook of Environmental Chemistry |
| Soggetto topico |
Environmental chemistry
Pharmacology Microbiology Pharmacovigilance Medical microbiology Environmental Chemistry Drug Safety and Pharmacovigilance Medical Microbiology Resistència als medicaments Efecte dels medicaments sobre els microorganismes Química ambiental |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-55065-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Antibiotic resistance in the environment: expert perspectives -- Antibiotic resistant bacteria in wildlife -- Genomic surveillance for One Health antimicrobial resistance: understanding human, animal, and environmental reservoirs and transmission -- Antibiotic resistance in pharmaceutical industry effluents and effluent-impacted environments -- Antibiotic resistance in municipal wastewater: A special focus on hospital effluents -- Control strategies to combat dissemination of antibiotic resistance in urban water systems -- Antibiotic resistance, sanitation and public health -- Antibiotic resistance and sanitation in India: current situation and future perspectives -- Mitigating antimicrobial resistance risks when using reclaimed municipal wastewater for agriculture -- Antibiotic resistance in soil -- Religious Mass Gathering (Hajj) and Antimicrobial Resistance: From Challenges to Opportunities -- Human movement and transmission of anti-microbial resistant bacteria. |
| Record Nr. | UNINA-9910416142403321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antitargets and drug safety / / edited by Lásló Urbán, Vinod F. Patel, and Roy J. Vaz
| Antitargets and drug safety / / edited by Lásló Urbán, Vinod F. Patel, and Roy J. Vaz |
| Pubbl/distr/stampa | Weinheim, Germany : , : Wiley-VCH, , [2015] |
| Descrizione fisica | 1 online resource (1266 p.) |
| Disciplina | 615.19 |
| Collana | Methods and principles in medicinal chemistry |
| Soggetto topico |
Drugs - Side effects
Drugs - Side effects - Prevention Drug interactions Drug development Drugs - Structure-activity relationships Drug-Related Side Effects and Adverse Reactions Protein Kinase Inhibitors - adverse effects Pharmacovigilance |
| ISBN |
3-527-67364-4
3-527-67366-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | section 1. General concept for target-based safety assessment -- section 2. Hepatic side effects -- section 3. Cardiovascular side effects -- section 4. Kinase antitargets -- section 5. Examples of clinical translation. |
| Record Nr. | UNINA-9910132261703321 |
| Weinheim, Germany : , : Wiley-VCH, , [2015] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antitargets and drug safety / / edited by Lásló Urbán, Vinod F. Patel, and Roy J. Vaz
| Antitargets and drug safety / / edited by Lásló Urbán, Vinod F. Patel, and Roy J. Vaz |
| Pubbl/distr/stampa | Weinheim, Germany : , : Wiley-VCH, , [2015] |
| Descrizione fisica | 1 online resource (1266 p.) |
| Disciplina | 615.19 |
| Collana | Methods and principles in medicinal chemistry |
| Soggetto topico |
Drugs - Side effects
Drugs - Side effects - Prevention Drug interactions Drug development Drugs - Structure-activity relationships Drug-Related Side Effects and Adverse Reactions Protein Kinase Inhibitors - adverse effects Pharmacovigilance |
| ISBN |
3-527-67364-4
3-527-67366-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | section 1. General concept for target-based safety assessment -- section 2. Hepatic side effects -- section 3. Cardiovascular side effects -- section 4. Kinase antitargets -- section 5. Examples of clinical translation. |
| Record Nr. | UNINA-9910823349403321 |
| Weinheim, Germany : , : Wiley-VCH, , [2015] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Comprehensive Healthcare Simulation: Pharmacy Education, Practice and Research [[electronic resource] /] / edited by Yaser Mohammed Al-Worafi
| Comprehensive Healthcare Simulation: Pharmacy Education, Practice and Research [[electronic resource] /] / edited by Yaser Mohammed Al-Worafi |
| Autore | Al-Worafi Yaser Mohammed |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (278 pages) |
| Disciplina | 615.10711 |
| Collana | Comprehensive Healthcare Simulation |
| Soggetto topico |
Pharmacy
Pharmacology Pharmacovigilance Public health administration Drug Safety and Pharmacovigilance Health Administration |
| ISBN | 3-031-33761-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I. Simulation in Pharmacy Education -- Overview of Simulation in Pharmacy Education -- Patient simulation in Pharmacy Education -- Fidelity simulation in Pharmacy Education -- Computer-based Simulation in Pharmacy Education -- Simulation for Introductory Pharmacy Practice Experience (IPPE) -- Simulation for Advanced Pharmacy Practice Experience (APPE) -- Simulation for Pharmacotherapy -- Simulation for Clinical Pharmacokinetics -- Simulation for Medication Safety -- Simulation for Pharmacology -- Simulation for Pharmaceutical Chemistry -- Simulation for Pharmaceutics and Pharmaceutical Industry -- Simulation for Drug Information and Poisons Services -- Simulation for Complementary and Alternative Medicines and Nutraceuticals -- Simulation for personalized medicine -- Simulation for Clinical Toxicology and Forensic Medicine -- In situ and mobile simulation in pharmacy education -- Facilitators of Simulation in Pharmacy Education -- Barriers of Simulation in Pharmacy Education -- Assessment, Evaluation and Feedback of Simulation in Pharmacy Education -- Effectiveness of simulation in pharmacy education -- Quality standards and recommendations of the simulation in pharmacy education -- Simulation training -- Part II. Simulation for Pharmacy Practice -- Overview of Simulation in Pharmacy Practice -- Simulation in Community Pharmacy Practice -- Simulation in Hospital Pharmacy Practice -- Simulation for communication skills assessment -- Simulation in patient care -- Simulation in the distance and online pharmacy practice: telepharmacy and telehealth -- Simulation for medication safety and patient safety practice -- Assessment, Evaluation and Feedback of Simulation in Pharmacy Practice -- Facilitators of Simulation in Pharmacy Practice -- Barriers of Simulation in Pharmacy Practice -- Quality standards and recommendations of Simulation in Pharmacy Practice -- Part III. Simulation for Pharmacy Research -- Overview of Simulation in Pharmacy Research -- Simulation for Drug Development -- Design simulation-based research in pharmacy -- Recruiting and train the simulated patients/persons -- Data analysis -- Ethics in simulation research -- Simulation research reports and publication -- Facilitators of simulation research -- Barriers of simulation research. |
| Record Nr. | UNINA-9910736020703321 |
Al-Worafi Yaser Mohammed
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Current chemical genomics and translational medicine
| Current chemical genomics and translational medicine |
| Pubbl/distr/stampa | Sharjah, U.A.E : , : Bentham Open, , [2013]-[2018] |
| Descrizione fisica | 1 online resource (6 volumes) |
| Soggetto topico |
Genomics
Translational Research, Biomedical Pharmacoepidemiology Pharmacovigilance |
| Soggetto genere / forma |
Fulltext
Internet Resources. Periodicals. |
| ISSN | 2213-9885 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910132238603321 |
| Sharjah, U.A.E : , : Bentham Open, , [2013]-[2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Current problems in pharmacovigilance / / Committee on Safety of Medicines [and] Medicines Control Agency
| Current problems in pharmacovigilance / / Committee on Safety of Medicines [and] Medicines Control Agency |
| Pubbl/distr/stampa | [London, : The Agency] |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Pharmacovigilance
Drug development - Standards Drugs - Quality control Pharmaceutical Preparations - adverse effects |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996197552403316 |
| [London, : The Agency] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Current problems in pharmacovigilance / / Committee on Safety of Medicines [and] Medicines Control Agency
| Current problems in pharmacovigilance / / Committee on Safety of Medicines [and] Medicines Control Agency |
| Pubbl/distr/stampa | [London, : The Agency] |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Pharmacovigilance
Drug development - Standards Drugs - Quality control Pharmaceutical Preparations - adverse effects |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910142821603321 |
| [London, : The Agency] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cutaneous Drug Hypersensitivity [[electronic resource] ] : Clinical Features, Mechanisms, Diagnosis, and Management / / edited by Andreas J. Bircher, Howard I. Maibach, Knut Brockow, Annick Barbaud
| Cutaneous Drug Hypersensitivity [[electronic resource] ] : Clinical Features, Mechanisms, Diagnosis, and Management / / edited by Andreas J. Bircher, Howard I. Maibach, Knut Brockow, Annick Barbaud |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (346 pages) |
| Disciplina | 615.778 |
| Soggetto topico |
Dermatology
Allergy Internal medicine Pharmacovigilance Primary care (Medicine) Family medicine Allergology Internal Medicine Drug Safety and Pharmacovigilance Primary Care Medicine General Practice and Family Medicine |
| ISBN | 3-030-82743-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I. General aspects of drug hypersensitivity -- Chapter 1. Terminology, classifications, chronology -- Chapter 2. Epidemiology -- Chapter 3. Clinical manifestations: Cutaneous signs and syndromes -- Chapter 4. Clinical manifestations: Other organs (kidney, gut, heart, brain etc.) -- Chapter 5. Danger signs in drug hypersensitivity and severity SCORES -- Chapter 6. Pathomechanisms in Drug Hypersensitivities -- Part II. Diagnostic methods -- Chapter 7. Skin tests -- Chapter 8. Serological tests -- Chapter 9. T cell tests -- Chapter 10. Basophil activation tests -- Chapter 11. Histopathology of drug induced exanthemas -- Part III. Management -- Chapter 12. Drug desensitization in immediate-type hypersensitivity -- Chapter 13. Documentation allergy card/pass -- Part IV. Drug hypersensitivity in specific populations -- Chapter 14. Children and Adolescents -- Chapter 15. HIV-Infection and AIDS -- Chapter 16. Oncology. immune checkpoint Inhibitors -- Chapter 17. MC releasing syndromes in drug hypersensitivity -- Part V. Eliciting Drugs -- Chapter 18. Penicillins -- Chapter 19. Cephalosporin Allergy -- Chapter 20. Other Antibiotics -- Chapter 21. Other Antiinfectious drugs -- Chapter 22. Analgesics and non-steroidal antiphlogistic drugs -- Chapter 23. Periinterventional hypersensitivity: Anesthetic drugs and materials -- Chapter 24. Muscle relaxants -- Chapter 25. Anticoagulants -- Chapter 26. Biological drugs -- Chapter 27. Hormones (delayed) -- Chapter 28. Vaccines -- Chapter 29. Antiepileptic and psychotropic drugs -- Chapter 30. PROTON PUMP INHIBITORS -- Chapter 31. Diagnostic agents -- Chapter 32. Hypersensitivity to blood pressure agents -- Chapter 33. Iron preparations -- Chapter 34. Vitamins and supplements -- Chapter 35. Anti-tumor drugs / Cytostatics -- Chapter 36. Photosensitizing drugs -- Chapter 37. Topically applied drugs -- Chapter 38. Additives: Preservatives, Antioxidants (sulfites), Colors, dyes and other. |
| Record Nr. | UNINA-9910768200103321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Ethical Innovation for Global Health [[electronic resource] ] : Pandemic, Democracy and Ethics in Research / / edited by Chieko Kurihara, Dirceu Greco, Ames Dhai
| Ethical Innovation for Global Health [[electronic resource] ] : Pandemic, Democracy and Ethics in Research / / edited by Chieko Kurihara, Dirceu Greco, Ames Dhai |
| Autore | Kurihara Chieko |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (331 pages) |
| Disciplina | 174.2 |
| Altri autori (Persone) |
GrecoDirceu
DhaiAmes |
| Soggetto topico |
Medical Ethics
Bioethics Pharmacovigilance Medical policy Pharmaceutical chemistry Drug Safety and Pharmacovigilance Health Policy Pharmaceutics |
| ISBN | 981-9961-63-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1 Introduction to Ethical innovation for global health: pandemic, democracy and ethics in research. Part 1 Relevant constructions from a middle-income country (MIC) and/or non-Western paradigms: Brazil, South Africa, Taiwan, South Korea, and Japan -- 2 Democracy restoration in Brazil, the constitutional guarantee of health as a right for all, giving rise to a universal health system (SUS) and of a National Research Ethics Commission -- 3 Equitable access to COVID-19 vaccines, vaccine research and Vaccine Apartheid on the African continent: challenges and recommendations -- 4 Response to Covid-19 pandemic and Ethical Innovations in Taiwan -- 5 Between truth and profit: Scientific misconduct case of human cloned embryonic stem cell and revisiting cases during COVID-19 pandemic -- 6 Therapeutic misconception as the basis for vaccine nationalism of Japan: a historical reflection and perspectives for global public health -- Part 2 Historical and international perspectives on the development of ethical principles in research involving humans -- 7 The Declaration of Helsinki as a living document: Revisiting its principles in a global pandemic -- 8 Hidden Medical War Crimes and the Emergence of Bioethics in Japan -- 9 From Nuremberg to Helsinki: Historicizing the Codification of Post-War Research Ethics -- 10 CIOMS research guidelines: Considering the needs of developing countries -- 11 Ethics of placebo-controlled trial: historical analysis including the experience of COVID-19 pandemic -- 12 Post-trial access: historical analysis considering the experience of COVID-19 pandemic -- 13 Our “WMA Declaration of Helsinki”: opinions and pro-posals from patient and public for research ethics -- Part 3 Alternative frameworks for innovation and drug development strategies -- 14 Medicines development for global health: Learning from COVID-19 vaccines R&D -- 15 Development of portfolios and pipelines of drugs for the treatment, prevention and control of neglected tropical diseases -- 16 Patient and Public Involvement (PPI) and pharmaceutical development through Open Innovation Processes ~ recent activities. |
| Record Nr. | UNINA-9910765490203321 |
|
Kurihara Chieko
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Herb-Drug Combinations [[electronic resource] ] : A New Complementary Therapeutic Strategy / / by Shanmugam Hemaiswarya, Pranav Kumar Prabhakar, Mukesh Doble
| Herb-Drug Combinations [[electronic resource] ] : A New Complementary Therapeutic Strategy / / by Shanmugam Hemaiswarya, Pranav Kumar Prabhakar, Mukesh Doble |
| Autore | Hemaiswarya Shanmugam |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (285 pages) |
| Disciplina | 016.61378 |
| Soggetto topico |
Pharmacology
Pharmacy Alternative medicine Pharmacovigilance Medicinal chemistry Complementary and Alternative Medicine Drug Safety and Pharmacovigilance Medicinal Chemistry Plantes medicinals Medicina alternativa Farmacologia |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-19-5125-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Introduction -- Chapter 2. Measuring Herb-drug interaction and Synergy -- Chapter 3. Herb-Herb and Food-drug interactions -- Chapter 4. Pharmacokinetic interactions in synergistic herb-drug combinations -- Chapter 5. Antagonistic Herb-drug interactions -- Chapter 6. Synergistic Herb-drug interactions against bacteria -- Chapter 7. Synergistic herb-drug interactions against tuberculosis -- Chapter 8. Synergistic herb-drug interactions against viral diseases -- Chapter 9. Synergistic herb interactions with cardiovascular drugs -- Chapter 10. Synergistic herb interactions with anticancer drugs -- Chapter 11. Synergistic herb interactions with antidiabetic drugs -- Chapter 12. Synergistic herb-drug interactions against obesity -- Chapter 13. Synergistic Herb-Drug Interactions in Neurological Disorders -- Chapter 14. Synergistic Herb-drug interactions with antifungal and antiparasitic agents -- Chapter 15. Computational methods to study herb-drug interactions -- Chapter 16. Regulations and guidelines involving synergistic plant-drug interactions -- Chapter 17. Clinical trials on synergistic herb-drug interactions -- Chapter 18. QFuture prospects on synergistic herb-drug interactions -- Chapter 19. Conclusion. |
| Record Nr. | UNINA-9910616380603321 |
|
Hemaiswarya Shanmugam
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
